Description
Cardiologie
- Prevention of heart failureby Massimo Piepoli on 1 juin 2026 at 15h07
Eur Heart J. 2026 May 30:ehag362. doi: 10.1093/eurheartj/ehag362. Online ahead of print.ABSTRACTHeart failure (HF) remains a major cause of morbidity, mortality and costs for the healthcare systems worldwide, despite advances in diagnostic and therapeutic strategies. The enhancement of preventive measures is now a priority, but effective […]
- Role of Neuroimaging Before Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrestby Edmond Wong on 1 juin 2026 at 14h57
Catheter Cardiovasc Interv. 2026 May 31. doi: 10.1002/ccd.70681. Online ahead of print.ABSTRACTBACKGROUND: Patients presenting following out-of-hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head-trauma.AIMS: We investigated the impact and utility of pre-coronary […]
- Reciprocal Mechanisms Linking Cancer and Cardiovascular Disease: Emerging Paradigms in Onco-Cardiologyby Shanmugananth Elayaperumal on 28 avril 2026 at 17h12
Curr Pharm Des. 2026 Apr 10. doi: 10.2174/0113816128456103260310045856. Online ahead of print.ABSTRACTBACKGROUND: There is a dual causal relationship between cancer and Cardiovascular Disease (CVD) due to similar risk factors and overlapping convergent molecular mechanisms. Factors such as hypertension, diabetes, dyslipidemia, obesity, smoking, […]
- Large Language Models in Cardiology: Systematic Reviewby Moran Gendler on 28 avril 2026 at 17h11
JMIR Cardio. 2026 Apr 16;10:e76734. doi: 10.2196/76734.ABSTRACTBACKGROUND: Large language models (LLMs) are increasingly used in health care, but their role in cardiology has not yet been systematically evaluated.OBJECTIVE: This review aimed to assess the applications, performance, and limitations of LLMs across diverse cardiology tasks, including […]
- Soft robotic devices for cardiovascular medicineby Xing-Yu Ji on 28 avril 2026 at 17h10
Nat Rev Cardiol. 2026 Apr 17. doi: 10.1038/s41569-026-01287-7. Online ahead of print.ABSTRACTConventional, rigid simulators and therapeutic devices for cardiovascular disease have several fundamental limitations, such as poor biomimetic fidelity, substantial surgical invasiveness and mismatch at the tissue-device interface. Soft robotic devices, […]
- Bridging the Gap: Cardiac Magnetic Resonance Guidelines to Clinical Practice in Sport Cardiologyby Chi Yang Chen on 28 avril 2026 at 17h09
Magn Reson Imaging Clin N Am. 2026 May;34(2):187-196. doi: 10.1016/j.mric.2026.01.003. Epub 2026 Feb 20.ABSTRACTSports cardiology has emerged as a critical subspecialty within cardiovascular medicine, focusing on the prevention, diagnosis, and management of cardiovascular conditions in athletes and physically active individuals. As participation […]
Maladies du cœur
- C-reactive protein-to-albumin ratio and the mortality of patients with heart failure: a meta-analysisby Yan Wang on 1 juin 2026 at 15h46
BMC Cardiovasc Disord. 2026 May 29. doi: 10.1186/s12872-026-05983-7. Online ahead of print.ABSTRACTBACKGROUND: The C-reactive protein-to-albumin ratio (CAR) reflects the interplay between systemic inflammation and nutritional status, and has recently been proposed as a prognostic biomarker in heart failure (HF). However, its association with […]
- Huatuo Zaizao Pills improve myocardial ischemia by inhibiting extracellular calcium influxby Nannan Wang on 1 juin 2026 at 15h39
Chin J Nat Med. 2026 Jun;24(6):745-756. doi: 10.1016/S1875-5364(26)61096-5.ABSTRACTCoronary heart disease (CHD), characterized by impaired coronary artery function, often results in myocardial ischemia, hypoxia, and necrosis, with clinical manifestations such as angina pectoris. Vascular smooth muscle cell (VSMC) hypercontraction, primarily […]
- Organ-Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Modelsby Jiajun Li on 1 juin 2026 at 15h10
J Am Heart Assoc. 2026 May 29:e047087. doi: 10.1161/JAHA.125.047087. Online ahead of print.ABSTRACTBACKGROUND: Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, has demonstrated cardioprotective and neuroprotective effects in preclinical myocardial infarction (MI) and ischemic stroke settings by reducing acute myocardial and cerebral […]
- Efficacy of SGLT2 Inhibitors in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: An Updated Systematic Review and Meta-Analysisby Tingyu Wang on 1 juin 2026 at 15h05
Ann Pharmacother. 2026 May 31:10600280261447498. doi: 10.1177/10600280261447498. Online ahead of print.ABSTRACTBACKGROUND: Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) constitute a substantial clinical burden with limited therapeutic options. While sodium-glucose […]
- Optimal duration of dual antiplatelet therapy for secondary stroke prevention: A systematic review and meta-analysisby André Richard da Silva Oliveira Filho on 1 juin 2026 at 14h59
J Clin Neurosci. 2026 May 31;151:112114. doi: 10.1016/j.jocn.2026.112114. Online ahead of print.ABSTRACTBACKGROUND: Dual antiplatelet therapy (DAPT) is recommended for secondary prevention after minor ischemic stroke or high-risk transient ischemic attack (TIA). Although short-term DAPT is widely used, uncertainty remains regarding how the balance […]
- Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in chronic obstructive pulmonary disease: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trialsby Chih-Chung Lin on 1 juin 2026 at 14h58
J Int Med Res. 2026 May;54(5):3000605261452493. doi: 10.1177/03000605261452493. Epub 2026 May 31.ABSTRACTObjectiveSodium-glucose cotransporter 2 inhibitors are widely used in the management of diabetes mellitus and have demonstrated substantial cardiovascular and renal protective effects, particularly in patients with heart failure. However, their […]
Maladies du cœur & Soins infirmiers
- A nurse-led age-friendly education model to prevent stroke in older adults: Implications for policy and practiceby Rasha Ahmed Fouad on 3 juin 2026 at 20h00
Appl Nurs Res. 2026 Jun;89:152086. doi: 10.1016/j.apnr.2026.152086. Epub 2026 Mar 22.ABSTRACTAIM: Evaluate the effectiveness of a nurse-led, age-friendly educational model based on the 4Ms framework in reducing stroke risk and promoting health-promoting behaviors among older adults.BACKGROUND: Stroke is a primary cause of disability and death […]
Chirurgies cardiaques
- Standardized End Point Definitions for Clinical Trials in Thoracic Aortic Repair: A Consensus Report From the ARCH-Academic Research Consortiumby Adam W Beck on 5 juin 2026 at 20h14
Circulation. 2026 Jun 2;153(22):1761-1780. doi: 10.1161/CIRCULATIONAHA.125.078803. Epub 2026 Jun 1.ABSTRACTInnovation in the treatment of ascending aorta and arch pathology with novel catheter-based and hybrid procedures has driven the need for a strategy to guide their safe application. The ARCH-ARC (Aortic Arch Academic Research Consortium) was […]
- The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2026 Update on Outcomes and Researchby Dawn S Hui on 5 juin 2026 at 20h13
Ann Thorac Surg. 2026 Jun 1:S0003-4975(26)00522-9. doi: 10.1016/j.athoracsur.2026.05.024. Online ahead of print.ABSTRACTThe Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) is one of the largest and most comprehensive clinical databases, containing data from over 8.6 million cardiac surgeries performed in the United States. […]
- Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk - a sub-analysis of the OPTION studyby Karen P Phillips on 5 juin 2026 at 20h01
Europace. 2026 Jun 2;28(6):euag093. doi: 10.1093/europace/euag093.ABSTRACTAIMS: Concerns have been raised over the safety and necessity of continuing oral anticoagulation (OAC) in patients following catheter ablation for atrial fibrillation (AF). OPTION demonstrated the safety and efficacy of left atrial appendage closure (LAAC) in a post-ablation […]
- Severe Aortic Stenosis Is Associated With Left Atrial Prothrombotic Flow That Persists Despite Valve Replacementby Marco Spartera on 28 avril 2026 at 17h49
J Am Heart Assoc. 2026 Apr 21;15(8):e045174. doi: 10.1161/JAHA.125.045174. Epub 2026 Apr 9.ABSTRACTBACKGROUND: Severe aortic stenosis (AS) is associated with ischemic stroke independently of atrial fibrillation or other causes. Even after aortic valve replacement (AVR), patients remain affected by a 6% 5-year stroke rate with knowledge gaps in the […]
Chirurgies cardiaques & Soins infirmiers
Autre veille d’intérêt : Chirurgie – Soins infirmiers
- The role of the cardiac surgical nurse practitioners in task shifting for efficient care in Japanby Shin-Ichi Tanida on 3 juin 2026 at 19h59
Surg Today. 2026 May 26. doi: 10.1007/s00595-026-03335-8. Online ahead of print.ABSTRACTPURPOSE: Nurse practitioners (NPs) were introduced in Japan to reduce physicians' workloads through task shifting. Three cardiac surgical NPs (CSNPs) were employed in our department. This study aimed to describe their clinical practices and evaluate their […]
Chirurgies vasculaires
- Machine Learning-Based Peri-Procedural Prediction Model for No-Reflow Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromeby Rensong Liu on 3 juin 2026 at 19h57
Am J Cardiol. 2026 May 27:S0002-9149(26)00367-X. doi: 10.1016/j.amjcard.2026.05.018. Online ahead of print.ABSTRACTCoronary no-reflow (NR) after percutaneous coronary intervention (PCI) predicts adverse prognosis in patients with acute coronary syndrome (ACS). This study aimed to establish a machine learning-based risk prediction model for […]
- Safety and Effectiveness of Saphenous Vein Graft Use for Retrograde Chronic Total Occlusion Percutaneous Coronary Interventionby Michaella Alexandrou on 3 juin 2026 at 19h40
Am J Cardiol. 2026 May 28:S0002-9149(26)00368-1. doi: 10.1016/j.amjcard.2026.05.019. Online ahead of print.ABSTRACTBACKGROUND: Contemporary data of saphenous vein graft (SVGs) use in retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) are limited.OBJECTIVES: We examined the frequency, characteristics, and outcomes of […]
- Two-Year Outcomes of Optical Coherence Tomography-Guided Percutaneous Coronary Intervention Stratified by Underlying Causes of Acute Coronary Syndromeby Myong Hwa Yamamoto on 3 juin 2026 at 19h39
Can J Cardiol. 2026 May 29:S0828-282X(26)00513-1. doi: 10.1016/j.cjca.2026.05.017. Online ahead of print.ABSTRACTBACKGROUND: Optical coherence tomography (OCT) can identify the underlying causes of acute coronary syndrome (ACS), including plaque rupture (PR), plaque erosion (PE), and eruptive calcified nodule (CN), which may have prognostic […]
- Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single-Center Studyby Krishna Prasad Kurpad on 3 juin 2026 at 19h39
Catheter Cardiovasc Interv. 2026 May 31. doi: 10.1002/ccd.70667. Online ahead of print.ABSTRACTBACKGROUND: Balancing ischemic and bleeding risks in patients undergoing percutaneous coronary intervention (PCI) who require anticoagulation remains a clinical challenge. While dual antithrombotic therapy (DAT) with a P2Y12 inhibitor and an oral […]
- Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactby Johny Nicolas on 3 juin 2026 at 19h33
Eur Heart J. 2026 Jun 1:ehag254. doi: 10.1093/eurheartj/ehag254. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Standard modifiable risk factors (SMuRFs), including hypertension, diabetes, hyperlipidaemia, and smoking, are prevalent among patients undergoing percutaneous coronary intervention (PCI). This study aimed to assess the prevalence […]
Chirurgies vasculaires & Soins infirmiers
Autre veille d’intérêt : Chirurgie – Soins infirmiers
- Impact of nurse-led postoperative education on health outcomes following endovascular aortic repair: a randomized trialby Johan Nilsson on 3 juin 2026 at 19h59
Sci Rep. 2026 May 23;16(1):16009. doi: 10.1038/s41598-026-54460-w.ABSTRACTThe purpose of this randomized controlled clinical trial was to investigate the health effects of an education-based intervention performed at a nurse-led clinic, for patients who underwent endovascular treatment for abdominal aortic aneurysm. Fifty-four adult patients were […]
Associations
- Author Correction to: "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology 41 (2025) 1857-1874]"by Primary Panel: on 28 avril 2026 at 17h13
Can J Cardiol. 2026 Apr 6:S0828-282X(26)00275-8. doi: 10.1016/j.cjca.2026.03.026. Online ahead of print.NO ABSTRACTPMID:41956442 | DOI:10.1016/j.cjca.2026.03.026
- Optimal lifelong roadmap post-ACS. A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESCby Roberto F E Pedretti on 28 avril 2026 at 17h08
Eur J Prev Cardiol. 2026 Apr 22:zwag236. doi: 10.1093/eurjpc/zwag236. Online ahead of print.ABSTRACTAcute coronary syndromes (ACS) remain a major cause of mortality and morbidity across Europe, with long-term outcomes still suboptimal despite advances in acute care. Current clinical guidelines primarily focus on the immediate post-event phase, […]
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


